The Scientist

» clinical trials

Most Recent

image: Week in Review: May 5–9

Week in Review: May 5–9

By | May 9, 2014

Synthetic base pairs replicated in vivo; cardiac stem cells questioned; miniature neurotransmissions and synaptic development; neurogenesis and memory loss; STAP saga continues

0 Comments

image: More Doubt Cast Over Cardiac Stem Cells

More Doubt Cast Over Cardiac Stem Cells

By | May 7, 2014

Contrary to previous reports, cell lineage tracing reveals stem cells in the heart rarely contribute to new muscle.

0 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

image: Making Better Mesenchymal Stem Cells

Making Better Mesenchymal Stem Cells

By | March 27, 2014

Scientists generate a new crop of stem cells that show therapeutic potential in mouse models of autoimmune diseases.

0 Comments

image: Saving Failing Hearts

Saving Failing Hearts

By | March 12, 2014

Inhibiting a small regulatory RNA appears to improve cardiac function in mice with surgically induced heart problems.

0 Comments

image: FDA Considers Three-Way Babies

FDA Considers Three-Way Babies

By | February 26, 2014

The agency is soliciting opinions on a new technology that has the potential to circumvent mitochondrial diseases by producing embryos using DNA from three people.

1 Comment

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

Popular Now

  1. That Other CRISPR Patent Dispute
    Daily News That Other CRISPR Patent Dispute

    The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.

  2. How Gaining and Losing Weight Affects the Body
    Daily News How Gaining and Losing Weight Affects the Body

    Millions of measurements from 23 people who consumed extra calories every day for a month reveal changes in proteins, metabolites, and gut microbiota that accompany shifts in body mass.

  3. Neurons Use Virus-Like Proteins to Transmit Information
  4. DOE-Sponsored Oak Ridge National Laboratory to Cut 100 More Jobs
AAAS